Opioid Treatments Could Get Survival Claim As US FDA Develops Protocol

Commissioner Gottlieb announces several actions in the works to promote development of new treatments for opioid addiction, including guidance on how to establish novel endpoints.

More from US FDA

More from Agency Leadership